RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 Seasons

Overview of attention for article published in JAMA: Journal of the American Medical Association, October 2025

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 113 news outlets
blogs: 6 blogs
twitter: 71 X users
facebook: 2 Facebook pages

video: 1 YouTube creator
guideline: 1 clinical guideline source
bluesky: 22 Bluesky users
podcasts: 1 podcast

Readers on

mendeley: 45 Mendeley

So far, Altmetric has seen 5 public wall posts from 2 users.

JAMA, 28 Oct 2025

In adults aged 60 years or older, RSV vaccines reduced RSV-associated hospitalizations over 2 seasons, although effectiveness…

JAMA Cardiology, 30 Aug 2025

From JAMA: In adults aged 60 years or older, RSV vaccines reduced RSV-associated hospitalizations over 2 seasons, although…

JAMA, 30 Aug 2025

In adults aged 60 years or older, RSV vaccines reduced RSV-associated hospitalizations over 2 seasons, although effectiveness…

JAMA, 30 Aug 2025

In adults aged 60 years or older, RSV vaccines reduced RSV-associated hospitalizations over 2 seasons, although effectiveness…

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity, including 1 additional Facebook posts.